Chia Tai Enterprises International Limited (HKG:3839)

Market Cap	1.74B +299.4%
Revenue (ttm)	4.17B +74.1%
Net Income	249.50M +187.0%
EPS	0.98 +187.0%
Shares Out	253.33M
PE Ratio	6.98
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,500
Average Volume	188,790
Open	6.83
Previous Close	6.87
Day's Range	6.83 - 6.87
52-Week Range	1.03 - 10.15
Beta	4.55
RSI	55.36
Earnings Date	May 8, 2026

About HKG:3839

Chia Tai Enterprises International Limited manufactures and sells animal health products and chlortetracycline in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment products portfolio consists of CTC premix and CTC hydrochloride, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brand names. The Industrial segment engages in the sa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 900
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3839

Financial Performance

In 2025, HKG:3839's revenue was $535.91 million, an increase of 74.14% compared to the previous year's $307.75 million. Earnings were $32.06 million, an increase of 187.03%.

Financial numbers in USD